Kip1 plays a key role in growth and development of the mammary epithelium and in breast cancer. p27
causative role in the initiation and progression of breast cancer (1, 2) . Estrogens and antiestrogens exert growth regulatory actions in normal and malignant breast epithelial cells through regulation of events in the G 1 phase of the cell cycle (for review, see Ref. 3) . p27
Kip1 is a key element of the G 1 phase regulatory apparatus. Removal of cyclin-dependent kinase (CDK) 1 
inhibitory activity associated with p21
Cip1 and p27 Kip1 in G 1 phase is essential to cyclin E-CDK2 activation and S phase entry (for review, see Refs. 4 and 5) . Along with other members of the kinase inhibitory protein (Kip) family (p21 Cip1 and p57 Kip2 ) p27
Kip1
serves both as an inhibitor of CDK2 activity in G 0 and early G 1 and as an assembly factor for cyclin D-CDK4/6 complexes in early G 1 (for review, see Ref.
5). Functional expression of p27
Kip1 is required for morphogenesis and normal proliferative responses in the mammary epithelium (6) . Mammary glands of p27
Kip1 (Ϫ/Ϫ) mice are underdeveloped compared with the wildtype, whereas the mammary epithelium of p27
Kip1 (ϩ/Ϫ) mice is hyperproliferative and susceptible to oncogene-induced tumorigenesis (6, 7) . Breast cancer isolates frequently exhibit decreased p27
Kip1 expression in addition to elevated expression of cyclin E (8 -12) . High levels of cyclin E-CDK2 activity in these tumors correlate with a high cyclin E/low p27 Kip1 phenotype (13) 
as does poor disease outcome. Expression of p27
Kip1 is an independent prognostic indicator for breast carcinomas and for a range of other tumor types (for review, see Ref. 14) .
Estrogens elicit active cyclin E-CDK2, and G 1 /S transition in estrogen receptor-positive MCF-7 breast cancer cells corresponding with decreasing levels of p27
Kip1 protein (15, 16 ) and a decrease in CDK inhibitory activity associated with both p27
Kip1 and p21 Cip1 (15) (16) (17) . Levels of p21 Cip1 and p27
Kip1
increase in MCF-7 cells after treatment of proliferating cells with antiestrogen, resulting in decreased CDK2 activity and growth arrest (18) . Inhibition of expression of either p21 Cip1 or p27
Kip1 with antisense oligonucleotides maintains active CDK2 and prevents antiestrogen-mediated G 1 blockade (19, 20) . p27 Kip1 levels are regulated in distinct fashion at different points in the cell cycle. After mitogenic stimulation of quiescent cells p27
Kip1 levels fall beginning in mid-G 1 , primarily mediated through regulation of protein stability by ubiquitin/proteasome-mediated proteolysis (Ref. 21 ; for review see Ref. 14) . p27
Kip1 protein expression is also regulated at the level of transcription (22) , translation (23, 24) , as well as through proteolytic processing independent of ubiquitination (25) and independent of the proteasome (26, 27) . Early in G 1 inhibitory activity of p21 Cip1 and p27 Kip1 toward CDK2 is removed by sequestration of the proteins into newly formed cyclin D-CDK4/6 complexes (for review, see Refs. 4 
and 5). CDK2 activation in MCF-7 cells corresponds both with p21
Cip1 / p27
Kip1 sequestration in early G 1 (16, 17, 28, 29) and with decreased p21
Cip1 /p27 Kip1 protein levels in mid-to late G 1 (15, 16, 19) , suggesting removal of CDK inhibitory activity in two phases after estrogen stimulation. Our recent studies indicate that the later phase of CDK inhibitor removal in MCF-7 cells requires the proteasome and proceeds in the absence of cyclin D-CDK4 complex formation or G 1 transit (28) . Further observations also indicated that down-regulation of p27
Kip1 expression in MCF-7 cells also corresponds with increased expression of Skp2 (29) , the F box component of the Skp1/Cul-1/F box protein (SCF) ubiquitin-protein ligase which binds p27 Kip1 phosphorylated on Thr 187 allowing its ubiquitination and destruction in the proteasome (30 -33) . Skp2 exhibits oncogenic potential in breast epithelial cells and is overexpressed in a subset of breast carcinomas (34) . Recent studies also indicate that p27
Kip1 ubiquitination can proceed in the absence of Skp2 (35) .
In the studies described herein we examined p27 Kip1 downregulation after estrogen stimulation of MCF-7 cells in detail with respect to the role of Skp2, as well as Skp2-independent mechanisms contributing to p27
Kip1 down-regulation. The results suggest that Skp2 participates in ubiquitination/degradation of p27
Kip1 in the nucleus of estrogen-treated MCF-7 cells and further demonstrate that Skp2 overexpression prevents antiestrogen-mediated growth arrest of MCF-7 cells by downregulating p27
Kip1 expression and maintaining CDK2 activity. In contrast, estrogen-induced down-regulation of p27
Kip1 proceeds in the absence of any increase in Skp2 expression in MCF-7 cells subjected to G 1 blockade with p16
Ink4a or roscovitine and appears to depend in this context upon export of p27
Kip1 to the cytoplasm. Our studies also indicate that this process requires phosphorylation of p27
Kip1 on Ser 10 as well as participation of the Ras/Raf-1/extracellular signal-regulated kinase (ERK) signaling pathway at a stage beyond phosphorylation of p27
Kip1 on this residue. In addition, enforced activation of the Ras/Raf-1/ERK pathway elicited cytoplasmic relocalization of p27
Kip1 and prevented growth arrest by antiestrogen.
EXPERIMENTAL PROCEDURES
Reagents and Antibodies-Cell culture media and antibiotics, 17␤-estradiol (E 2 ), histones, fetal bovine serum (FBS), glutathione-agarose beads, RNase A, propidium iodide, monoclonal (M2) and rabbit polyclonal anti-FLAG antibodies, and other chemicals were from Sigma Chemical Co. ICI 182,780 was supplied by Dr. Alan Wakeling at Zeneca Pharmaceuticals (Alderly Park, Cheshire, UK). Protein A/G beads, antibodies to CDK2 (M2), p27
Kip1 (C19), p21 Cip1 (C19), Skp2 (H435), Cul-1 (H213), ERK2 (C14), Cks-1 (FL79), and Skp1 (H6) were from Santa Cruz Biotechnology (Santa Cruz, CA). Monoclonal anti-actin, and antihemagglutinin epitope antibodies were from Roche Applied Science.
Monoclonal antibody to p27
Kip1 was from BD Biosciences, and antibodies to green fluorescent protein (GFP) and E2F-1 were from Labvision/ Neomarkers (Freemont, CA). Antibodies to active mitogen-activated protein kinases (MAPK) were from Promega (Madison, WI). [␥-
32 P]ATP, and Tran 35 S-label were from ICN (Irvine, CA). Horseradish peroxidaseconjugated secondary antibodies were from Jackson Immunoresearch (West Grove, PA). Fluorochrome-labeled secondary antibodies to mouse and rabbit IgG (Alexa Fluor 350 and 488) were from Molecular Probes (Eugene, OR). MG-132, Myc epitope antibodies (clone 9E10), PD98059, and roscovitine were from Calbiochem. Leptomycin B (LMB) was provided by M. Yoshida (36) .
Cell Culture, Viral Vectors, and Transfections-MCF-7 cells were a gift from R. P. Shiu (37) and were maintained as described previously (28) . MCF-7/tTA (Tet-off) cells were derived by transfection with pTetoff (Clontech). Cells were growth arrested by 2-3 days of culture in phenol red-free Dulbecco's modified Eagle's medium with 0.1% FBS and 20 nM ICI 182,780 as described previously (28) (16) . Chemical stock solutions were prepared in ethanol (17␤-estradiol, ICI 182,780, LMB) or dimethyl sulfoxide (PD98059, roscovitine), and control cultures received equal amounts of solvents as vehicle controls where appropriate.
Plasmid vectors for p16
Ink4a (pBI-p16) and cyclin E (pMTcycE) were provided by J. Lukas (38) , and vector for constitutively active ERK kinase (MEK, EE mutant) was provided by M. Cobb. Plasmids for Skp2 and FLAG-tagged p27
Kip1 (wild-type, and S10A/S10E mutants) have been described previously (39 -41) . Plasmid vector for human Skp2 was provided by M. Pagano (31) . The dominant-negative ERK2 and RasN17 plasmids were provided by G. L. Johnson (42) , the Ras V12S35 plasmid was provided by C. M. Counter (43) , and the Cul-1(1-452) plasmid was provided by Z. Q. Pan (44) . The YFPp27
Kip1 expression plasmid was provided by J. Slingerland (45) . Transfections were carried out using LipofectAMINE PLUS transfection reagent (Invitrogen).
Control and antisense Skp2 oligonucleotides (Sigma/Genosys) based upon a previous publication (31) were prepared in partially phosphothiorated form to minimize destruction by cellular nucleases and were transfected into growth-arrested MCF-7 cells using Lipofectin transfection reagent (Invitrogen). The nucleotide sequences of the oligonucleotides were: antisense Skp2, 5Ј-CCTGGGGGATGTTCTCA-3Ј; control, 5Ј-CCGCTCATCGTATGACA-3Ј. Oligonucleotides were transfected for 3 h at a final concentration of 1 M with 18 l of liposome reagent.
Replication-defective adenoviral vectors for expression of p16
Ink4a
, p27
Kip1
, and control (␤-galactosidase) adenovirus have been described previously (28, 46, 47) as has the adenoviral Skp2 vector (murine Skp2) (39) . Adenoviral vector for the constitutively active Raf-1 caax mutant was provided by J. R. Nevins (48) . Adenoviruses were propagated in human embryonic kidney 293 cells (ATCC), and viral lysates for use in experiments were titered by a standard plaque assay to determine plaque-forming units (pfu)/ml.
Flow Cytometric Analysis-For flow cytometric analysis MCF-7 cells were harvested in saline-EDTA, fixed in cold 70% ethanol, and stored at Ϫ20°C. Fixed cells were subsequently washed, treated with 100 g/ml RNase A, and stained with 50 g/ml propidium iodide. Analysis of DNA content was performed in a BD Biosciences FACScan with a minimum of 15,000 events collected for analysis using BD Biosciences Cell Quest software. For analysis of DNA synthesis bromodeoxyuridine (BrdUrd) was added to the medium as described in the text and BrdUrd incorporation measured by flow cytometry using fluorescein-labeled antibodies to BrdUrd (BD/Pharmingen) according to the manufacturer's protocol.
Western Blot Analysis and Immune Complex Kinase Assays-Cells were lysed as described previously (15, 28) in ice-cold Nonidet P-40 lysis buffer (20 mM Tris, pH 7.5, 250 mM NaCl, 0.5% Nonidet P-40, 0.1 mM EDTA, 1 mM NaOV 4 , 10 mM NaF, 10 g/ml aprotinin, 10 g/ml leupeptin, 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride), with brief sonication and centrifugation to remove cellular debris. Nuclear/cytoplasmic cell fractionation was carried out by lysis in hypotonic buffer with 0.02% digitonin as described previously (41) . Western blots were performed as described in detail previously (28) . Equal protein loading was verified for all lysate blots by Ponceau S staining and/or by reprobing for actin expression. In experiments measuring expression of ectopic FLAG-p27
Kip1 by Western blotting transfection was verified by coexpression of GFP (pEGFPN1, Clontech) and analysis by fluorescent microscopy/Western blotting with anti-GFP antibodies. Histone kinase assays were performed with anti-CDK2 immune precipitates as described (15, 28) using equal amounts of lysate proteins.
Metabolic Labeling and Pulse-Chase Analysis of p27 Kip1 Stability-MCF-7 cells in 6-well plates were growth arrested and, to facilitate detection of labeled p27
, were infected with Adp27 at 5 pfu/cell with or without Adp16, AdSkp2, or control adenovirus as required. 12 h after infection cells were treated as described, and at appropriate times cultures were labeled for 1 h with [ 35 S]Met/Cys as described previously (15, 28) . For the chase, monolayers were washed twice with fresh, complete medium and incubated for the indicated times before lysis in ice-cold Nonidet P-40 lysis buffer as described above. Immunoprecipitations were performed with 1 g of p27 Kip1 (C19) antibodies and protein A/G-agarose beads and analyzed as described (15, 28) .
Subcellular Localization of p27
Kip1 by Microscopy-MCF-7 cells grown on glass coverslips were transfected with the YFPp27
Kip1 plasmid vector (45) or FLAG-p27
Kip1 vectors (40, 41) alone or in combination with appropriate vectors as indicated. After treatment the cells were fixed with 3% paraformaldehyde, mounted on slides, and cells with nuclear versus nuclear/cytoplasmic YFPp27
Kip1 were enumerated visually on an Olympus IMT-2 fluorescent microscope. For immunofluores-cent localization of FLAG-p27
Kip1 or epitope-tagged cotransfectants, fixed cells were permeabilized with 0.25% Triton X-100 and stained with the appropriate antibodies and fluorochrome-labeled secondary antibodies. For quantification, a minimum of 400 cells were counted for each determination, and results were derived from at least three independent experiments. Statistical analysis was performed with GraphPad Prism 3.0 software.
RESULTS

Skp2 Expression in Response to E 2 Is Prevented by G 1 Blockade, but p27
Kip1 Down-regulation Is Maintained-Estrogen stimulation of G 0 /G 1 -arrested MCF-7 cells leads to down-regulation of p27
Kip1 protein expression corresponding with cyclin E-CDK2 activation and preceding entry into S phase (15, 16, 28) . As we reported previously, p27
Kip1 down-regulation in MCF-7 cells is prevented by chemical inhibitors of the proteasome but is not affected in MCF-7 cells transduced with an adenoviral vector for p16
Ink4a despite effective inhibition of cyclin D-CDK complex formation, CDK2 activation, and cell cycle transit (28) . Degradation of p27
Kip1 via the ubiquitinproteasome pathway is facilitated by interaction with the F box protein Skp2, which in conjunction with CKS1 binds p27 Kip1 phosphorylated on Thr 187 by CDK2 and mediates interactions with the SCF ubiquitin-protein ligase (30 -33, 49, 50) . Skp2 levels increase in estrogen-stimulated MCF-7 cells (29) . Similar to other studies (31), the amounts of Skp2 and CKS1/2 increased in MCF-7 cells after estrogen treatment, beginning ϳ9 h after release from growth arrest (Fig. 1A) . Increasing Skp2 expression thus correlates with the decline in p27 Kip1 levels which is evident in E 2 -treated MCF-7 cells by ϳ9 -10 h in most experiments and maintained throughout S phase (Fig.  1A , data not shown). As reported in earlier studies (31) , levels of Skp1 and Cul-1 remain essentially constant in these cultures (data not shown).
Earlier studies indicate that Skp2 expression is cell cycleregulated, with the protein appearing in mid-to late G 1 phase (31, 51, 52) . In contrast to the lack of any effect of p16
Ink4a -mediated cell cycle blockade on p27
Kip1 down-regulation (28), increased expression of Skp2 and CKS1/2 elicited by E 2 was prevented by G 1 blockade enforced by overexpression of p16 Ink4a (Fig. 1B) . Cell cycle progression and increased Skp2 expression in response to E 2 were also effectively inhibited by the chemical CDK inhibitor roscovitine (Fig. 1C) , but downregulation of p27
Kip1 was unaffected. These results indicate that Skp2 expression in MCF-7 cells is cell cycle-dependent and that p27 Kip1 down-regulation induced in MCF-7 cells by estrogen is not strictly linked to Skp2 expression. Thus, to the extent that p27
Kip1 down-regulation in G 1 is expected to rely upon increasing Skp2 expression in mid-G 1 , this would suggest that alternate mechanisms participate in p27
Kip1 destruction in MCF-7 cells. Because Skp2/p27
Kip1 interaction requires CDK2-dependent phosphorylation of p27
Kip1 on Thr 187 (33, (53) (54) (55) it is also of interest that CDK2 inhibition by p16
Ink4a or roscovitine did not prevent p27
Kip1 down-regulation. Skp2 Overexpression Down-regulates p27 Kip1 
and Maintains Proliferation of MCF-7 Cells under Conditions of Mitogen and
Estrogen Withdrawal-Skp2 has been characterized as an oncogene (56, 57) and elicits p27
Kip1 down-regulation, activation of CDK2, and cell cycle progression when overexpressed in quiescent cells (32) . We studied the effects of Skp2 overexpression on MCF-7 cells undergoing antiestrogen-mediated growth arrest. Treatment of proliferating MCF-7 cells with the steroidal antiestrogen ICI 182,780 causes the cells to arrest in G 0 /G 1 with repression of CDK4/CDK2 kinase activities and increased levels of both p21
Cip1 and p27 Kip1 (18) . Our studies indicated that expression of endogenous Skp2 was reduced in antiestrogen-treated cultures ( Fig. 2A) . Transduction of MCF-7 cells with adenoviral Skp2 vector maintained CDK2 activity in ICI 182,780-treated cultures at levels comparable with those in proliferating cells and prevented growth arrest elicited by antiestrogen as measured by flow cytometry ( Fig. 2A) . Reversal of antiestrogen-induced growth arrest by Skp2 overexpression corresponded with decreased p27
Kip1 expression , but levels of p21
Cip1 in ICI 182,780-treated cultures were unaffected ( Fig. 
2A, lower panels). Measurements of p27
Kip1 stability in growtharrested control and Skp2-transduced cells by pulse-chase analysis and confirmed that p27
Kip1 down-regulation elicited by Skp2 expression in antiestrogen-arrested cells were reflective of decreased stability of the protein (Fig. 2B ). In addition, overexpression of Skp2 in growth-arrested MCF-7 cells elicited active CDK2 and S phase entry in G o /G 1 -arrested MCF-7 cells in the absence of E 2 or other mitogenic stimulus (Fig. 2C) , and this correlated with a reduction in p27
Kip1 levels.
Nuclear Export of p27
Kip1 Is Required for Down-regulation under Conditions of G 1 Blockade-Recent studies suggest that destruction of p27
Kip1 is mediated by multiple proteolytic path-
FIG. 1. Expression of Skp2 is cell cycle-dependent and is not required for down-regulation of p27
Kip1
. A, Western blot analysis of expression of p27
and components of the SCF ubiquitin-protein ligase in lysates of growth-arrested MCF-7 cells treated with E 2 for the indicated times (note: the CKS1 antibody cross-reacts with CKS2). B, cell cycle-dependent expression of Skp2 and CKS1. MCF-7 cells transduced with control (␤gal) and p16
Ink4a adenoviral vectors as indicated were growth arrested, treated for 20 h with E 2 , and lysates were assayed for expression of Skp2, CKS1/2, p27
, p16
Ink4a , and actin by Western blotting (top five panels) and for CDK2-associated histone kinase activity (bottom panel), showing the blockade of CDK2 activation by p16
Ink4a
. C, growth-arrested MCF-7 cells were treated for 20 h with E 2 as indicated or with E 2 and 25 M roscovitine (lane 3). Expression of p27
Kip1
, Skp2, and actin was assessed by Western blotting. The cell cycle status of these cultures based on DNA content analysis of the proliferative fraction (S phase plus G 2 /M) is given below the figure. ways (25, 58) . These pathways are, in part, independent of Skp2 and instead rely either upon a constitutive ubiquitination apparatus in the cytoplasm (35, 58) or proteolytic degradation independent of ubiquitination (25) (26) (27) . In addition, several studies indicate that p27
Kip1 undergoes CRM1-dependent nuclear export in response to mitogenic stimuli, including estrogen (45, 59) , as well as upon ectopic expression of Jab1/CSN5, a component of the COP9 signalosome (60) . Studies of Jab1/ CSN5-mediated export indicate that p27
Kip1 does not contain nuclear export sequences and that direct binding interactions between p27
Kip1 and Jab1/CSN5 may serve to "bridge" p27
Kip1 and CRM1 (61) . Recent studies in our laboratories and others have suggested that p27 Kip1 and CRM1 may interact directly (41, 45) . We examined the role of nuclear export in p27 Kip1 down-regulation elicited by E 2 in MCF-7 cells with interest in cells subjected to G 1 
blockade with p16
Ink4a where Skp2 expression is impaired. Our earlier studies indicate that Skp2 is localized to the nucleus in MCF-7 cells (29) . LMB disrupts the interaction between CRM1 and nuclear export sequences in exported proteins (36) and prevents export of p27
Kip1 in mitogen-stimulated fibroblast (41, 59) . Pulse-chase analysis of p27
Kip1 stability in MCF-7 cells confirmed that p27 Kip1 was destabilized in vivo by E 2 treatment of p16
Ink4a -transduced, antiestrogen-arrested cultures and was, in turn, stabilized by he addition of LMB along with E 2 (Fig. 3A) . Transduction of E 2 /LMB-treated cultures with Skp2 completely overcame the effects of LMB and destabilized p27
Kip1 to a degree beyond that provided by E 2 alone. Similar to our results in previous studies (29) 
LMB inhibited p27
Kip1 down-regulation in measurements of steady-state expression levels (Fig. 3B, third lane) , and transduction with Skp2 vector led to virtual elimination of p27
Kip1 despite LMB treatment (Fig. 3B, fourth 
lane). This could lend support to a role for Skp2 in mediating p27
Kip1 destruction in the nuclear compartment in MCF-7 cells, i.e. p27
Kip1 destruction is facilitated when LMB maintains nuclear localization of the protein and Skp2 is overexpressed. The results thus may suggest that p27
Kip1 destruction induced by estrogeninMCF-7cellstransducedwithp16
Ink4a requiresCRM1-dependent export of the molecule to the cytoplasm because of a lack of Skp2 expression.
CRM1-dependent nuclear export of p27 Kip1 at the G 0 /G 1 transition requires phosphorylation of the molecule at Ser 10 and subsequent mitogen stimulation (41, 59 ). p27
Kip1 is phosphorylated on Ser 10 in MCF-7 cells growth arrested with antiestrogen and is exported to the cytoplasm after estrogen treatment (59) . Phosphorylation on this site represents a large portion of total p27
Kip1 phosphorylation, and mutation of this residue to alanine (S10A mutant) prevents interaction with CRM1 and nuclear export of p27
Kip1 in response to mitogen, favoring nuclear localization of the molecule (41, 59) . To test further whether Skp2 action in MCF-7 cells is oriented to p27
Kip1 in the nuclear compartment, cells were transfected with vectors for epitope-tagged wild-type p27
Kip1 or the S10A mutant with and without adenoviral Skp2 transduction. Skp2 expression down-regulated both wild-type p27
Kip1 and the S10A mutant in mitogen-and estrogen-deprived MCF-7 cells (Fig. 3C) . Immunofluorescent microscopy confirmed that transfected, exogenous Skp2 and the S10A mutant of p27 was assessed by pulse-chase labeling and immunoprecipitation of labeled p27
Kip1 for 12 h after E 2 treatment as described under "Experimental Procedures." Quantitative analysis based on densitometry is shown as a graph. C, MCF-7 cells were growth arrested by treatment with antiestrogen (2 days total) and E 2 treated or transduced with adenoviral vector for Skp2. Cultures were assayed 20 h later for BrdUrd uptake (6-h pulse), CDK2 activity, and by Western blotting for expression of Skp2 and p27
Kip1
. localized to the nucleus (Fig. 3D) . Further experiments verified that exogenous Skp2, whether plasmid-or viral vector-derived, is localized to the nucleus and that enforced Skp2 expression did not affect the subcellular localization of wild-type p27
Kip1 or p27
Kip1 S10A under a variety of conditions (data not shown). Our results thus support a role for Skp2 in destruction of p27
Kip1 localized to the nucleus. We further investigated the role of nuclear export and Ser 10 phosphorylation using ectopic expression of the epitope-tagged p27 Kip1 variants with mutations on Ser 10 (40). Estrogen treatment of transfected MCF-7 cells down-regulated the levels of wild-type p27
Kip1 and the S10E mutant of p27 Kip1 , which is efficiently exported from the nucleus (41) as well as those of p27
Kip1 S10A, which is not (Fig. 4A) . To assess more directly the role of the SCF ubiquitin-ligase in p27
Kip1 down-regulation elicited by E 2 we cotransfected p27
Kip1 S10A and p27 Kip1 S10E along with a Cul-1(1-452) truncation mutant that interferes with SCF function (44) . The Cul-1(1-452) mutant prevented down-regulation of p27
Kip1 S10A in response to E 2 ( Fig. 4B ) but had no effect upon removal of p27 Kip1 S10E. In addition, downregulation of the nonexported S10A mutant was inhibited in MCF-7 cells transfected with antisense Skp2 oligonucleotides (Fig. 4C ), but control oligonucleotides had no effect. Antisense Skp2 oligonucleotides reduced expression of the protein in these cells by ϳ50%. These results, along with those in Fig. 3 , support a model in which E 2 -induced down-regulation of p27
Kip1 in the nuclear compartment is dependent upon Skp2 and function of the SCF ubiquitin-ligase and further suggest that Skp2-independent degradation of p27
Kip1 requires export of the protein.
Ras/Raf/MEK/ERK Activation Relocalizes p27 Kip1 to the Cytoplasm and Is Required for Nuclear Export and Downregulation of p27
Kip1 Induced by Estrogen-Subcellular localization and degradation of p27
Kip1 is regulated by MAPKs, i.e. ERKs 1 and 2, activated through the Ras/Raf-1/MEK/ERK pathway (62) (63) (64) (65) (66) . With respect to growth regulation by estrogen our earlier studies indicated that dominant-negative RasN17 prevented down-regulation of ectopic p27
Kip1 and S phase entry induced by estrogen treatment of MCF-7 cells (28, 67) . Estrogens activate ERKs in MCF-7 cells (68 -70) , and chemical inhibitors of ERK activation inhibit estrogen-induced accumulation of cyclin D1 (67) . We performed experiments to examine the role of active ERKs in p27
Kip1 down-regulation elicited by estrogen in MCF-7 cells. Cotransfection of dominant-negative ERK2 prevented down-regulation of both the p27
Kip1 S10A and p27 Kip1 S10E mutants in response to estrogen (Fig. 5A) , leading to accumulation of p27
Kip1 in estrogentreated cells (lanes 3 and 7) as well as in growth-arrested cells
FIG. 3. Stability of p27
Kip1 is increased by LMB in MCF-7 cells overexpressing p16
Ink4a
. A, Skp2 reverses the stabilizing effects of LMB.
MCF-7 cells were growth arrested and transduced with p16
Ink4a adenoviral vector (80 pfu/cell) along with p27 Kip1 adenoviral vector (5 pfu/cell). After 24 h, cultures were treated with E 2 , E 2 plus LMB, or E 2 plus LMB in combination with adenoviral Skp2 transduction (40 pfu/cell). After 12 h, the stability of de novo p27
Kip1 was measured by pulse-chase analysis as described under "Experimental Procedures." The quantitative results based on densitometry are presented as a graph. B, MCF-7 cells were growth arrested and treated with E 2 , E 2 plus LMB, or E 2 plus LMB in combination with adenoviral Skp2. Lysates prepared after 24 h were assayed for p27
Kip1
, Skp2, and actin protein expression by Western blotting. C, MCF-7 cells were transfected with vectors for FLAG-tagged wild-type p27
Kip1 or the p27
S10A mutant along with pEGFPN1 as a transfection control and transduced with control or Skp2 adenoviral vectors (10 pfu/cell). After 12 h in complete medium, cells were cultured in medium with 0.2% FBS and 20 nM ICI 182,780 for 40 h. Protein expression levels of FLAG-tagged exogenous p27
Kip1 (wild-type and S10A mutant) and FLAG-Skp2 were analyzed by Western blotting with rabbit anti-FLAG antibodies. The blot was reprobed for expression of actin and GFP as loading controls. D, MCF-7 cells were transfected with p27 Kip1 S10A along with control plasmid or plasmid vector for human Skp2 and cultured as in C.
Cellular localization of p27
Kip1 S10A and Skp2 was visualized by immunostaining with anti-FLAG (M2) monoclonal antibodies and rabbit polyclonal antibodies to Skp2.
(data not shown). This suggests a role for ERKs in this process independent of the requirement for Ser 10 
phosphorylation of p27
Kip1 and is in agreement with earlier studies, which indicated that Ser 10 on p27 Kip1 is not a likely target of ERK activity (40, 59) .
CDK2-dependent phosphorylation of p27 Kip1 at Thr 187 and interaction with SCF Skp2 are required for p27 Kip1 degradation at G 1 /S but not in G 1 phase (58). Consistent with these studies and with respect to our own observations in p16
Ink4a -expressing or roscovitine-treated cells we found that down-regulation of the nonexported S10A mutant of p27
Kip1 was prevented by coexpression of a dominant-negative CDK2 mutant leading to marked accumulation of this mutant in E 2 -treated cells (Fig.  5A, lane 4) . In contrast, down-regulation of the exported, S10E mutant of p27
Kip1 after E 2 was largely unaffected by dominantnegative CDK2 with no accumulation of this mutant being
FIG. 4. Down-regulation of the nonexported p27
Kip1 S10A mutant requires SCF function. A, MCF-7 cells were transfected with plasmid vectors for FLAG-tagged wild-type, S10E, or S10A mutants of p27
Kip1 along with control vector followed by growth arrest and 24 h treatment with E 2 . Expression of the transfected forms of p27
Kip1 was assayed by Western blotting of whole cell lysates with anti-FLAG antibodies. B, MCF-7 cells were transfected with control plasmid or the Cul-1(1-452) vector along with pEGFPN1 and the indicated p27
Kip1 vectors. Expression of FLAG Cul-1(1-452) and the FLAG-tagged p27
Kip1 mutants was assayed by Western blotting with anti-FLAG antibodies using lysates prepared 20 h after E 2 treatment of G 0 /G 1 -arrested cells. Blots were subsequently reprobed for GFP expression. Panels reflect different exposures derived from the same gel caused by differences in overall expression levels. C, MCF-7 cells were transfected with p27 Kip1 S10A and growth arrested. After 2 days, cultures were transfected with control oligonucleotides, antisense Skp2 oligonucleotides, or with lipid alone as indicated and treated with E 2 . After 24 h, lysates were analyzed for expression of the p27 Kip1 S10A mutant and Skp2 by Western blotting.
FIG. 5. Active MAPK is required for E 2 -induced p27 Kip1 down-regulation. A, MCF-7 cells were transfected with plasmid vectors for p27
Kip1 S10A (lanes 1-4) , p27 Kip1 S10E (lanes 5-8), along with control plasmid or plasmids expressing dominant-negative MAPK (DNErk2) or dominant-negative CDK2 as indicated. After growth arrest and 24-h E 2 treatment, protein expression levels of the p27 Kip1 mutants were measured by Western blotting with anti-FLAG antibodies. Overall transfection and expression of the (non-epitope-tagged) dominant-negative cotransfectants were monitored by reprobing the blots for ERK2, CDK2, and GFP. B, Chemical inhibition of CDK2 causes accumulation of the p27 Kip1 S10A mutant.
MCF-7 cells were transfected with plasmids for p27
Kip1 S10A (left panel) or p27 Kip1 S10E (right panel) along with control vector. After growth arrest, cells were treated with E 2 (all cultures) and 25 M roscovitine (Rosc.) as indicated. Expression of Skp2 and the p27 Kip1 mutants was measured by Western blot analysis of lysates prepared after 20 h of treatment. evident (Fig. 5A, lane 8) . Also, addition of roscovitine to estrogen-treated cultures caused accumulation of p27 Kip1 S10A but not p27
Kip1 S10E (Fig. 5B) . Along with results given above this confirms that Skp2-dependent, nuclear destruction of p27 Kip1 requires CDK2 activity and also suggests that active ERKs participate in p27
Kip1 down-regulation through actions that lie outside of Ser 10 phosphorylation of p27 Kip1 . Constitutive MEK/MAPK activation renders MCF-7 cells resistant to growth arrest by antiestrogens through altered expression, localization, and function of p27
Kip1 (66) . We utilized transfection of YFPp27
Kip1 fusion protein (45) to explore further the relationship between active signal transduction pathways and p27
Kip1 localization in MCF-7 cells. Localization of YFPp27
Kip1 was exclusively nuclear in 75-80% of cells under conditions of mitogen/estrogen withdrawal (Fig. 6A, graph and  photomicrographs) . Cotransfection of the constitutively active MEK EE mutant yielded readily observable cytoplasmic localization of YFPp27
Kip1 in the majority of cells under these conditions as did expression of the RasV12S35 mutant that preferentially activates the Raf-1/MEK/ERK pathway (43) . Coexpression of cyclin E, which readily overcomes antiestrogen-and p16
Ink4a
-mediated G 1 arrest in MCF-7 cells (28), did not increase the extent of cytoplasmic localization of YFPp27
Kip1
. Cell cycle analysis determined, however, that MEK EE , RasV12S35, and cyclin E did not abrogate G 1 arrest enforced in these cultures by the combination of antiestrogen and YFPp27
Kip1 and would indicate that cytoplasmic localization of YFPp27
Kip1 is independent of cell cycle transit (data not shown).
To examine the consequence of Raf-1/MEK/ERK activation on expression of endogenous p27
Kip1 and proliferation of MCF-7 cells we transduced cultures with a constitutively active Raf-1 caax mutant and examined the cell cycle profile along with Kip1 , Skp2, and actin. C, MCF-7 cells were infected with ␤-galactosidase and Raf-1 caax adenoviral vectors as above and treated 2 days with ICI 182,780 in medium with 0.2% FBS. Lysates were analyzed with phospho-specific antibodies to active MAPK and with antibodies to ERK2 (note: the ERK2 antibodies cross-react with ERK1). D, control and AdRaf-1 caax -transduced cultures were treated for 24 h with ICI 182,780, and the cells were fractionated into nuclear (N) and cytoplasmic (C) compartments. The proportion of p27
Kip1 in the subcellular fractions was determined by Western blotting and densitometry and is represented by the ratios given below the figure. As a control for fractionation, blots were reprobed for expression of E2F-1 as a nuclear marker.
D, bottom graph, MCF-7 cultures transfected with YFPp27
Kip1 and transduced with control, Skp2, and Raf-1 caax adenoviral vectors (10 pfu/cell) were cultured as above in A were analyzed microscopically for subcellular localization of YFPp27
Kip1
.
The enumerated percentage of cells with evident cytoplasmic YFPp27
Kip1 is given as percent of cells with evident cytoplasmic p27 Kip1 Ϯ S.D. based on counts of 400 -500 cells over three separate cultures. The indications for statistics are as above in A.
the expression of p27
Kip1 and Skp2 after treatment of the cultures with antiestrogen. Similar to results with Skp2 overexpression in Fig. 2 , MCF-7 cells expressing Raf-1 caax did not undergo G 1 arrest after a 48-h treatment with ICI 182,780 and exhibited levels of p27
Kip1 comparable with those in untreated, proliferating cells (Fig. 6B, top panel) . Skp2 expression was minimal in antiestrogen-treated cells as before and was expressed at even lower levels in antiestrogen-treated cultures transduced with Raf-1 caax (Fig. 6B , middle panel) despite continuing proliferation in these cultures. Analysis with antibodies to active ERKs confirmed that MCF-7 cells transduced with Raf-1 caax exhibited higher activity of ERKs 1 and 2 relative to controls (Fig. 6C) . Nuclear/cytoplasmic fractionation of control and Raf-1 caax -transduced MCF-7 cells treated with antiestrogen indicated that cells transduced with Raf-1 caax exhibit a higher proportion of cytoplasmic p27
Kip1 than controls (Fig. 6D,  top 
panel). Visualization of YFPp27
Kip1 localization in mitogenand estrogen-deprived cultures transduced with control or Raf-1 caax vectors confirmed the increased cytoplasmic localization in Raf-1 caax -transduced cultures (graph at bottom of Fig. 6D ). The results in Fig. 6 indicate that down-regulation of endogenous p27
Kip1 induced by Raf-1 caax is sufficient for maintenance of proliferation in antiestrogen-treated cells and is associated with cytoplasmic relocalization of p27
Kip1 as described in earlier studies (66) . This proceeds independently of Skp2 expression and indicates that Skp2 expression is, in this case, disconnected from cell cycle progression. We examined the role of ERKs in nuclear export of p27
Kip1 induced by E 2 . Assays of ERK activation under our conditions of growth arrest confirmed that E 2 treatment elicits phosphorylated, active ERK within 15 min of stimulation, and this activation is maintained for up to 2 h (Fig. 7A) . The extent of ERK activation elicited by E 2 is consistently less, however, than that elicited by growth factors (data not shown). Two recent studies indicate that p27 Kip1 undergoes nuclear export by 8 -12 h after E 2 treatment of MCF-7 cells (45, 59) . In our studies estrogen treatment doubled the percentage of cells exhibiting cytoplasmic YFPp27
Kip1 8 h after treatment of G 0 /G 1 -arrested cells (Fig. 7B,  left panel) . Inhibition of ERK activation with either the chemical MEK inhibitor PD98059 or by cotransfection with dominant-negative ERK2 decreased the number of cells exhibiting cytoplasmic YFPp27
Kip1 (Fig. 7B, both panels) . The dominantnegative RasN17 mutant also prevented cytoplasmic relocalization of YFPp27
Kip1 , but cotransfection with p16 Ink4a had no effect. Fractionation of MCF-7 cells verified that PD98059 decreased the amount of endogenous p27
Kip1 in the cytoplasm 8 h after E 2 treatment (Fig. 7C) . These results indicate that ERK activation is a requisite aspect of estrogen action in promoting p27
Kip1 export. Further experiments shown in Fig. 7D demonstrated that inhibition of ERK activation by PD98059 or dominantnegative ERK2 coexpression prevents export of p27 Kip1 S10E as demonstrated above for the wild-type protein.
Given that p27
Kip1 S10E mimics Ser 10 -phosphorylated p27
Kip1
, this would indicate that the role of ERK activation with respect to p27
Kip1 export is separate from Ser 10 phosphorylation per se. Our experiments also verified, however, that p27 Kip1 S10A is not exported in response to E 2 , thus confirming the requisite nature of phosphorylation on this residue (Fig. 7D, right panel) . DISCUSSION 
Regulation of CDK inhibitor expression, and particularly that of p27
Kip1 , has emerged as a critical aspect of growth control in normal mammalian cells and as a frequent point of dysregulation in a wide variety of tumors including breast carcinomas (for review, see Ref. 14) . Intracellular concentrations of p27
Kip1 are regulated primarily through the ubiquitinproteasome pathway (Ref. 21 ; for review, see Ref. 14) . Expression of p27
Kip1 at low levels in human tumors is frequently the result of increased proteolytic degradation of the protein rather than allelic loss (10, 71) .
Studies using MCF-7 cells as a model of growth regulation by estrogens have demonstrated the importance of p21
Cip1 /p27
Kip1 removal in estrogen-stimulated proliferative responses (15) (16) (17) 28) and the participation of these CDK inhibitors in growth arrest by antiestrogens (for review, see Ref.
3). Prior to the onset of p27 Kip1 destruction, the earliest phase of CDK inhibitor removal in E 2 -stimulated MCF-7 cells depends on de novo cyclin D1 synthesis and redistribution of p27
Kip1 /p21 Cip1 from cyclin E-CDK2 complexes to newly formed cyclin D1-CDK4 complexes (17, 28, 29) . Steady-state levels of both p27
Kip1 and p21
Cip1 decline in MCF-7 cells after E 2 stimulation, demonstrable within 8 -10 h of treatment (15, 16, 19, 28) . One recent study has associated the early phase of E 2 -induced cyclin E-CDK2 activation to decreased synthesis of p21
Cip1 coupled with increased synthesis of cyclin D1 (72) . This same study indicated that p27
Kip1 synthesis was increased 8 -10 h after E 2 treatment, but stability of the protein was decreased markedly (72) .
Our studies now strongly indicate that down-regulation of p27
Kip1 protein levels induced in MCF-7 cells by estrogen proceeds through at least two mechanisms separable by blockade of G 1 transit and differing in their reliance on Skp2 and nuclear export of p27 Kip1 (Ref. 28 
and this work). Both modes of p27
Kip1 down-regulation ultimately result in proteolytic destruction of the molecule similar to evolving concepts of p27 Kip1 elimination arising from studies in other cell systems (26, 35, 58) . Our evidence would suggest that estrogen promotes relocalization of p27
Kip1 in early to mid-G 1 , dependent upon prior Ser 10 phosphorylation, CRM1, and active ERK signaling kinases, delivering p27
Kip1 to Skp2-independent systems in the cytoplasm for degradation (25-27, 35, 41, 45, 59) . Later in G 1 , and in S phase, increasing expression of Skp2 and the appearance of CDK2 activity targets p27
Kip1 remaining in the nucleus for destruction mediated through Thr 187 phosphorylation and ubiquitination. Skp2 overexpression prevents antiestrogen-mediated growth arrest of MCF-7 cells and is sufficient for p27
Kip1 downregulation and cell cycle entry in growth-arrested cells.
Degradation of p27 Kip1 is promoted by CDK2-dependent phosphorylation on Thr 187 allowing interaction with the SCF Skp2 ubiquitin-protein ligase through binding interactions with Skp2 and CKS1 (30 -33, 49, 50) . Periodicity of p27
Kip1 expression through the cell cycle has been explained by the cell cycle dependence of Skp2 expression (51, 52) and CDK2 activity (73, 74) . We found previously that estrogen-induced downregulation of p27
Kip1 in MCF-7 cells was mediated through proteasome-dependent destruction beginning in mid-G 1 yet was independent of CDK2 activation and cell cycle progression (28) . Conversely, p27
Kip1 destruction did correspond with increasing Skp2 expression (29) . The studies described herein expand upon these observations and demonstrate that estrogens likely regulate expression of p27
Kip1 in MCF-7 cells both through Skp2-dependent pathways as well as through mechanisms that do not rely upon interactions with SCF Skp2 . Most importantly, p27
Kip1 instability and down-regulation of steadystate levels of p27
Kip1 were readily apparent under conditions of G 1 arrest where Skp2 expression was not up-regulated by E 2 . The potential for growth promotion by Skp2 in MCF-7 cells is readily demonstrable, however, because Skp2 overexpression effectively destabilized p27
Kip1 and promoted S phase entry in growth-arrested cells in the absence of mitogen. Overexpression of Skp2 thus represents a potential mechanism of antiestrogen resistance in breast cancer cells (34) .
While these studies were under way one of our laboratories has published an independent study demonstrating that ubiquitin/proteasomedependent degradation of p27
Kip1 at the G 0 -G 1 transition is independent of Skp2 and occurs in the cytoplasm in mouse embryo fibroblasts (35) . This activity has been attributed to a heterodimeric Kip1 ubiquitinylation-promoting complex located in the cytoplasm.
2 Skp2-, and CDK2-dependent p27
Kip1 destruction occurs in the nuclear compartment later in G 1 and in S phase (35, 58) . Similarly our studies have demonstrated abundant p27
Kip1 -ubiquitinating activity in lysates of MCF-7 cells irrespective of G 1 blockade and decreased Skp2 abundance (data not shown). Recent studies have also demonstrated that proteasome-and calpain-mediated mechanisms contribute to p27
Kip1 elimination without any requirement for ubiquitination (25) (26) (27) .
The demonstration that overexpression of Jab1/CSN5 elicited nuclear export/degradation of p27
Kip1 suggested a requirement for relocalization of the molecule prior to degradation (60) , and recent studies have further characterized the mechanisms underlying p27
Kip1 export. Jab1/CSN5 promotes export and degradation of p27
Kip1 through a CRM1-dependent mechanism (60, 61) , possibly involving interactions of p27
Kip1 with the adaptor protein Grb2 in the cytoplasm (75) . Export of p27
Kip1 to the cytoplasm after growth factor stimulation may also inhibit Grb2/SOS interactions and serve to limit Ras effector functions (76) . Nuclear export of p27
Kip1 requires phosphorylation on Ser 10 and mitogen stimulation (41, 59) . Ser 10 phosphorylation of p27 Kip1 has been related to a growth factordependent, nuclear kinase, hKIS (77) , and to Akt (78 Ink4a , and the effects of LMB were reversed by Skp2. One recent study has suggested that stabilization of p27
Kip1 by LMB in MCF-7 cells is not reflective of disrupted p27
Kip1 /CRM1 interactions and may result from more general effects of LMB on cell cycle progression (45) . Our studies consistently indicate, however, that nuclear export and down-regulation of p27
Kip1 are unaffected by inhibition of G 1 transit (Ref. 28 and this work). Degradation of the nonexported S10A mutant of p27
Kip1 was inhibited by antisense Skp2 oligonucleotides and by coexpression of the Cul-1(1-452) mutant that interferes with SCF function. Consistent with participation of SCF Skp2 in elimination of p27 Kip1 in the nucleus, the S10A mutant of p27
Kip1 , which localizes to that cellular compartment, was down-regulated by enforced Skp2 expression in mitogen-and estrogen-deprived cells. We find no evidence that Skp2 expression alters the subcellular localization of p27
Kip1 . The Ras/Raf-1/MEK/ERK pathway has been implicated in regulation of expression and subcellular localization of p27 and ERK activity induced by Erb2/neu overexpression promotes degradation of p27
Kip1 and cytoplasmic localization of both p27
Kip1 and Jab1/CSN5 (63, 64) . Degradation of p27
Kip1
induced by active ERK is independent of CDK2 and Thr 187 phosphorylation (65) . In addition, one recent study has shown that constitutive MEK/ERK activation contributes to antiestrogen resistance in breast cancer cell lines by altering phosphorylation, expression, and the CDK2 inhibitory function activity of p27 Kip1 (66) . We found that active MEK, and the selective MEK-activating RasV12S35 mutant, elicited cytoplasmic localization of p27
Kip1 in antiestrogen-treated cultures. Furthermore, Raf-1 caax prevented p27 Kip1 accumulation and cell cycle arrest in antiestrogen-treated MCF-7 cells, corresponding with ERK activation and cytoplasmic localization of p27
Kip1 . Estrogens activate the Ras/Raf/MEK/ERK signal transduction pathway in MCF-7 cells, and this pathway has been associated with promotion of growth and cell survival in MCF-7 cells and in estrogen-responsive tissues in vivo (63, (67) (68) (69) (70) 80) . In our previous studies dominant-negative Ras inhibited downregulation of ectopic p27
Kip1 in response to E 2 (28) . In the present study we found that dominant-negative ERK2 prevented E 2 -induced down-regulation of both the exported p27
Kip1 S10E mutant and the p27 Kip1 S10A mutant for which degradation appears to be restricted to the nucleus, leading to accumulation of both mutants in E 2 -treated cells. This may suggest a role for ERK in p27
Kip1 destruction in either the cytoplasmic or nuclear compartments. Accordingly, dominantnegative ERK2 and the MEK inhibitor PD98059 inhibited nuclear export of p27
Kip1 , and this inhibition was independent of Ser 10 phosphorylation based on blockade of the p27 Kip1 S10E mutant that mimics p27
Kip1 phosphorylated on this residue. Our results thus suggest that ERKs participate in p27 Kip1 export elicited by estrogen at a step subsequent to Ser 10 phosphorylation and more broadly indicate an increasingly complex role for ERK activation in regulating the fate of p27
Kip1 subsequent to estrogen/mitogen stimulation. A recent study indicates that calpain-mediated p27
Kip1 degradation in choroid melanoma cells depends upon nuclear export and on MAPK activity, which appears to regulate p27
Kip1 phosphorylation indirectly (26) .
In conclusion, our studies indicate that p27 Kip1 down-regulation in response to estrogen stimulation of MCF-7 cells is likely mediated both through Skp2-dependent mechanisms as well as through mechanisms that are independent of Skp2 and rely instead upon nuclear export of p27
Kip1 to active proteolytic systems in the cytoplasm. Significantly, our studies also indicate a role for active ERKs in nuclear export and down-regulation of p27
Kip1 elicited by E 2 . Removal of p27 Kip1 CDK inhibitory activity in G 1 thus appears to occur in at least three phases in this model system: sequestration in cyclin D-CDK complexes in early G 1 , export/cytoplasmic degradation in mid-G 1 , and Skp2-dependent degradation in the nuclear compartment beginning late in G 1 phase. A simplified version of the interactions regulating p27
Kip1 function in response to estrogen is shown in Fig. 8 .
In addition, our studies suggest modes of p27 Kip1 downregulation mediated by Skp2 or through oncogene-activated signaling pathways that may contribute to antiestrogen resist- , and as-yet undefined residues regulates subcellular localization, CDK inhibitory activity and stability of p27
Kip1 . Ras/Raf-1/ERK activation elicits CRM1-dependent export of p27 Kip1 export, removing it from the inhibitory, nuclear pool and promoting its degradation. In the cytoplasm, p27
Kip1 participates in formation of de novo cyclin D-CDK4 complexes induced by estrogen, and their import, leading to sequestration of p27
Kip1 in this cellular compartment and possibly in the nucleus. Skp2 mediates ubiquitin/proteasome-mediated destruction of p27
Kip1 localized to the nucleus, dependent on CDK2 activity and possibly ERKs. Undefined aspects of p27
Kip1 regulation including the targets of ERK action, the site of p27 Kip1 degradation mediated by Skp2, and the possible participation of exported p27
Kip1 in interactions with cyclin D-CDK complexes or other effectors are indicated as (??). Given that most of the p27 Kip1 in quiescent breast cancer cells is bound to cyclin E-CDK2 (83, 84) , the equilibria existing between bound p27
Kip1 and free, exportable p27 Kip1 in the nucleus also remain unknown. Additional references for this figure have been cited in the Introduction and "Discussion."
ance in breast cancer cells. Our results demonstrate potent growth promotion by Skp2 with respect to antagonizing growth suppression by antiestrogens. A study published when this manuscript was in preparation (34) has demonstrated that Skp2 is overexpressed in a subset of estrogen receptor-negative/Her-2-negative breast cancers and that Skp2 overexpression abrogates antiestrogen-mediated growth arrest of MCF-7 cells. Similarly, our studies also indicate that cytoplasmic relocalization of p27
Kip1 elicited by Ras/Raf-1/ERK activation can contribute to antiestrogen resistance in this model system. Previous studies have demonstrated a role for p27
Kip1 in formation and nuclear localization of active cyclin D-CDK4 complexes as well as the particular importance of p27
Kip1 and cyclin D-CDK4 to normal growth and function of the mammary epithelium (5, 6, 81, 82) . Better understanding of the control exerted by estrogen over p27
Kip1 export, degradation, and growth-promoting interactions with cyclin D-CDK4 complexes will clarify the complex interactions regulating growth in normal breast epithelium that ultimately contribute to tumor formation, antiestrogen resistance, and disease progression.
